000 01562 a2200505 4500
005 20250513115757.0
264 0 _c19970818
008 199708s 0 0 eng d
022 _a0028-3908
024 7 _a10.1016/s0028-3908(96)00161-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAkunne, H C
245 0 0 _aThe pharmacology of the novel and selective sigma ligand, PD 144418.
_h[electronic resource]
260 _bNeuropharmacology
_cJan 1997
300 _a51-62 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAnimals
650 0 4 _aBehavior, Animal
_xdrug effects
650 0 4 _aBrain
_xmetabolism
650 0 4 _aCalcium
_xmetabolism
650 0 4 _aCells, Cultured
650 0 4 _aCyclic GMP
_xmetabolism
650 0 4 _aGuinea Pigs
650 0 4 _aHaloperidol
_xpharmacology
650 0 4 _aIsoxazoles
_xmetabolism
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMotor Activity
_xdrug effects
650 0 4 _aN-Methylaspartate
_xpharmacology
650 0 4 _aPyridines
_xmetabolism
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aRats, Wistar
650 0 4 _aReceptors, sigma
_xdrug effects
700 1 _aWhetzel, S Z
700 1 _aWiley, J N
700 1 _aCorbin, A E
700 1 _aNinteman, F W
700 1 _aTecle, H
700 1 _aPei, Y
700 1 _aPugsley, T A
700 1 _aHeffner, T G
773 0 _tNeuropharmacology
_gvol. 36
_gno. 1
_gp. 51-62
856 4 0 _uhttps://doi.org/10.1016/s0028-3908(96)00161-x
_zAvailable from publisher's website
999 _c9126042
_d9126042